Market Exclusive

Abbott Laboratories (NYSE:ABT) reported earnings of $0.66 per share beating Walls Streets expectations.

Abbott Laboratories (NYSE:ABT) reported 9/30/2017 earnings this Morning, coming in at $0.66 per share, beating Wall Street’s estimates of $0.65 per Share. Revenue for the quarter came in at $6.83 billion beating analyst estimates of $6.72 billion

Analyst Coverage For Abbott Laboratories (NYSE:ABT)
These are 5 Hold Ratings, 9 Buy Ratings .
The current consensus rating for Abbott Laboratories (NYSE:ABT) is Buy (Score: 2.64) with a consensus target price of $55.50 , a potential (0.80% upside)Recent Insider Trading for Abbott Laboratories (NYSE:ABT)

Dividend History for Abbott Laboratories (NYSE:ABT)

Recent Trading for Abbott Laboratories (NYSE:ABT) Shares of Abbott Laboratories closed the previous trading session at with shares trading hands.

Exit mobile version